BioLight Life Sciences Ltd. (TLV: BOLT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 588.20
0.00 (0.00%)
Jan 20, 2025, 10:15 AM IDT
BioLight Life Sciences Revenue
BioLight Life Sciences had revenue of 114.00K ILS in the half year ending June 30, 2024, with 1,800.00% growth. This brings the company's revenue in the last twelve months to 198.00K, up 117.58% year-over-year. In the year 2023, BioLight Life Sciences had annual revenue of 118.00K with 87.30% growth.
Revenue (ttm)
198.00K
Revenue Growth
+117.58%
P/S Ratio
135.33
Revenue / Employee
49.50K
Employees
4
Market Cap
26.80M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 62.35B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 588.75M |
| Bait Bakfar | 102.08M |
| Novolog (Pharm-Up 1966) | 1.73B |
| Ilex Medical | 982.96M |
| BrainsWay | 143.60M |
| SofWave Medical | 210.53M |